Inactivation of corticotropin-releasing hormone-induced insulinotropic role by high-altitude hypoxia

Diabetes

Volumn 64, Issue 3, 2015, Pages 785-795

  Hao, Ke ^a   Kong, Fan Ping ^a   Gao, Yu Qi ^b   Tang, Jia Wei ^a   Chen, Jian ^b   Evans, A Mark ^c   Lightman, Stafford L ^d   Chen, Xue Qun ^a   Du, Ji Zeng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL L TYPE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CALCIUM; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; GLUCOSE BLOOD LEVEL; HYDROCORTISONE; INSULIN; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ADULT; ALTITUDE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NONHUMAN; NORMAL HUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; ADOLESCENT; ALTITUDE; ANIMAL; ANOXIA; ANTAGONISTS AND INHIBITORS; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PANCREAS; SPRAGUE DAWLEY RAT; YOUNG ADULT;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; ALTITUDE; ANIMALS; ANOXIA; BLOOD GLUCOSE; CALCIUM; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; HUMANS; HYDROCORTISONE; INSULIN; MALE; PANCREAS; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; YOUNG ADULT;

EID: 84928214419     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0500     Document Type: Article

References (50)

1. Basnyat B, Murdoch DR. High-altitude illness. Lancet 2003;361:1967-1974
2. Wu TY, Ding SQ, Liu JL, et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol 2007;8:88-107
3. Wu TY, Ding SQ, Zhang SL, et al. Altitude illness in Qinghai-Tibet railroad passengers. High Alt Med Biol 2010;11:189-198
4. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 1997;504:241-249
5. Barnholt KE, Hoffman AR, Rock PB, et al. Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab 2006;290:E1078-E1088
6. Simler N, Grosfeld A, Peinnequin A, Guerre-Millo M, Bigard AX. Leptin receptor-deficient obese Zucker rats reduce their food intake in response to hypobaric hypoxia. Am J Physiol Endocrinol Metab 2006;290:E591-E597
7. Lee EJ, Alonso LC, Stefanovski D, et al. Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia. Eur J Appl Physiol 2013;113:467-478
8. Gamboa JL, Garcia-Cazarin ML, Andrade FH. Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle. Am J Physiol Regul Integr Comp Physiol 2011;300:R85-R91
9. Chintamaneni K, Bruder ED, Raff H. Effects of age on ACTH, corticosterone, glucose, insulin, and mRNA levels during intermittent hypoxia in the neonatal rat. Am J Physiol Regul Integr Comp Physiol 2013;304:R782-R789
10. Chen XQ, Dong J, Niu CY, Fan JM, Du JZ. Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat. Endocrinology 2007;148:3271-3278
11. Prentki M, Matschinsky FM, Madiraju SR. Metabolic signaling in fuelinduced insulin secretion. Cell Metab 2013;18:162-185
12. White MF. Insulin signaling in health and disease. Science 2003;302:1710-1711
13. Chandra R, Liddle RA. Neural and hormonal regulation of pancreatic secretion. Curr Opin Gastroenterol 2009;25:441-446
14. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004;44:525-557
15. Huising MO, van der Meulen T, Vaughan JM, et al. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc Natl Acad Sci U S A 2010;107: 912-917
16. Schmid J, Ludwig B, Schally AV, et al. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proc Natl Acad Sci U S A 2011;108:13722-13727
17. Kanno T, Suga S, Nakano K, Kamimura N, Wakui M. Corticotropin-releasing factor modulation of Ca2+ influx in rat pancreatic beta-cells. Diabetes 1999;48: 1741-1746
18. O'Carroll AM, Howell GM, Roberts EM, Lolait SJ. Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic beta-cells. J Endocrinol 2008;197:231-239
19. Jeong KH, Sakihara S, Widmaier EP, Majzoub JA. Impaired leptin expression and abnormal response to fasting in corticotropin-releasing hormone-deficient mice. Endocrinology 2004;145:3174-3181
20. Wang X, Meng FS, Liu ZY, et al. Gestational hypoxia induces sex-differential methylation of Crhr1 linked to anxiety-like behavior. Mol Neurobiol 2013;48:544-555
21. Xu JF, Chen XQ, Du JZ, Wang TY. CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats. Peptides 2005;26:639-646
22. Sutton R, Peters M, McShane P, Gray DW, Morris PJ. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 1986;42: 689-691
23. Roach RC, Bärtsch P, Oelz O, Hackett PH; Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In Hypoxia and Mountain Medicine. Sutton JR, Houston CS, Coates G, Eds. Burlington, VT, Charles S. Houston, 1993, p. 272-274
24. Zhao Y, Ren JL, Wang MY, et al. Codon 104 variation of p53 gene provides adaptive apoptotic responses to extreme environments in mammals of the Tibet plateau. Proc Natl Acad Sci U S A 2013;110:20639-20644
25. Quesada I, Nadal A, Soria B. Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes 1999; 48:2390-2397
26. Chen XQ, Kong FP, Zhao Y, Du JZ. High-altitude hypoxia induces disorders of the brain-endocrine-immune network through activation of corticotropinreleasing factor and its type-1 receptors. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2012;28:481-487
27. Carlin KM, Vale WW, Bale TL. Vital functions of corticotropin-releasing factor (CRF) pathways in maintenance and regulation of energy homeostasis. Proc Natl Acad Sci U S A 2006;103:3462-3467
28. Dionne KE, Colton CK, Yarmush ML. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 1993;42:12-21
29. Hyder A, Laue C, Schrezenmeir J. Metabolic aspects of neonatal rat islet hypoxia tolerance. Transpl Int 2010;23:80-89
30. Sekine N, Cirulli V, Regazzi R, et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. J Biol Chem 1994;269:4895-4902
31. Doliba NM, Wehrli SL, Vatamaniuk MZ, et al. Metabolic and ionic coupling factors in amino acid-stimulated insulin release in pancreatic beta-HC9 cells. Am J Physiol Endocrinol Metab 2007;292:E1507-E1519
32. Tanaka T, Nagashima K, Inagaki N, et al. Glucose-stimulated single pancreatic islets sustain increased cytosolic ATP levels during initial Ca2+ influx and subsequent Ca2+ oscillations. J Biol Chem 2014;289:2205-2216
33. Johnson RA, Shoshani I. Kinetics of "P"-site-mediated inhibition of adenylyl cyclase and the requirements for substrate. J Biol Chem 1990;265:11595-11600
34. Hardie DG. Metformin-acting through cyclic AMP as well as AMP? Cell Metab 2013;17:313-314
35. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 2007;275:43-61
36. Kainuma E, Watanabe M, Tomiyama-Miyaji C, et al. Association of glucocorticoid with stress-induced modulation of body temperature, blood glucose and innate immunity. Psychoneuroendocrinology 2009;34:1459-1468
37. Lambillotte C, Gilon P, Henquin JC. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 1997;99:414-423
38. Ullrich S, Berchtold S, Ranta F, et al. Serum-and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion. Diabetes 2005;54:1090-1099
39. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 2010;17:481-493
40. Panossian A, Hambardzumyan M, Hovhanissyan A, Wikman G. The adaptogens rhodiola and schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol. Drug Target Insights 2007;2:39-54
41. Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 2009;75:105-112
42. Nijsen MJ, Croiset G, Stam R, et al. The role of the CRH type 1 receptor in autonomic responses to corticotropin-releasing hormone in the rat. Neuropsychopharmacology 2000;22:388-399
43. Kalsbeek A, Bruinstroop E, Yi CX, Klieverik LP, La Fleur SE, Fliers E. Hypothalamic control of energy metabolism via the autonomic nervous system. Ann N Y Acad Sci 2010;1212:114-129
44. Schobersberger W, Leichtfried V, Mueck-Weymann M, Humpeler E. Austrian Moderate Altitude Studies (AMAS): benefits of exposure to moderate altitudes (1,500-2,500 m). Sleep Breath 2010;14:201-207
45. Schobersberger W, Schmid P, Lechleitner M, et al. Austrian Moderate Altitude Study 2000 (AMAS 2000). The effects of moderate altitude (1,700 m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur J Appl Physiol 2003;88:506-514
46. de Mol P, Fokkert MJ, de Vries ST, et al. Metabolic effects of high altitude trekking in patients with type 2 diabetes. Diabetes Care 2012;35: 2018-2020
47. de Mol P, de Vries ST, de Koning EJ, Gans RO, Tack CJ, Bilo HJ. Increased insulin requirements during exercise at very high altitude in type 1 diabetes. Diabetes Care 2011;34:591-595
48. Moore K, Vizzard N, Coleman C, McMahon J, Hayes R, Thompson CJ. Extreme altitude mountaineering and type 1 diabetes; the Diabetes Federation of Ireland Kilimanjaro Expedition. Diabet Med 2001;18:749-755
49. Blüher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003;299:572-574
50. Taguchi A, Wartschow LM, White MF. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007;317:369-372